Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Scientific Reports|March 12, 2025
Dynamic correlation of environmental regulation, technological innovation, and corporate carbon emissions: empirical evidence from China listed companiesLinjie Feng, Yi Shi, Zhenjie Yang, et al.Cancer Gene Therapy|October 30, 2004
Tumor-specific intravenous gene delivery using oncolytic adenovirusesJinghui Zhan, Yi Gao, Wensheng Wang, et al.Journal for Immunotherapy of Cancer|May 10, 2023
OncoVEXmGM-CSFexpands tumor antigen-specific CD8+ T-cell response in preclinical modelsJuan Estrada, Jinghui Zhan, Petia Mitchell, et al.Journal of Agricultural and Food Chemistry|June 10, 2026
Synergistic Dual-Nano Delivery Systems for Enhanced Foliar Deposition and Disease ControlXinglong Xu, Jinghui Zhan, Cailing Meng, et al.Nanomaterials (Basel, Switzerland)|April 11, 2025
Fabrication and Characterization of a Novel Solid Nano-Dispersion of Emamectin Benzoate with High Dispersibility and WettabilityYing Li, Qing Wang, Junqian Pan, et al.Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|June 12, 2013
Novel anti-c-Mpl monoclonal antibodies identified multiple differentially glycosylated human c-Mpl proteins in megakaryocytic cells but not in human solid tumorsJinghui Zhan, Barbara Felder, Aaron R Ellison, et al.Advanced Healthcare Materials|December 3, 2025
Multi-Architecture Nanovaccines Against Pseudorabies Virus and Particle Size-Governed Immune Activation MechanismsMeng Zhang, Chunxin Wang, Cailing Meng, et al.Hybridoma (2005)|June 27, 2006
Generation and characterization of monoclonal antibodies to human keratinocyte growth factor receptorPing Wei, Jinghui Zhan, Shuying Liu, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|May 18, 2022
Characterization of an Anti-CD70 Half-Life Extended Bispecific T-Cell Engager (HLE-BiTE) and Associated On-Target Toxicity in Cynomolgus MonkeysTod Harper, Amy Sharma, Sarav Kaliyaperumal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2017
Local Delivery of OncoVEXmGM-CSF Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte-Associated Protein BlockadeAchim K Moesta, Keegan Cooke, Julia Piasecki, et al.Pageof 2